Axsome Therapeutics Inc (AXSM)
71.52
+0.35
(+0.49%)
USD |
NASDAQ |
Apr 25, 16:00
71.75
+0.23
(+0.32%)
After-Hours: 20:00
Axsome Therapeutics Cash from Investing (TTM): -0.582M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.582M |
| September 30, 2023 | -0.756M |
| June 30, 2023 | -0.451M |
| March 31, 2023 | -53.56M |
| December 31, 2022 | -53.70M |
| September 30, 2022 | -53.52M |
| June 30, 2022 | -53.71M |
| March 31, 2022 | -0.492M |
| December 31, 2021 | -0.308M |
| September 30, 2021 | -0.3278M |
| June 30, 2021 | -0.084M |
| March 31, 2021 | -0.0666M |
| December 31, 2020 | -0.0459M |
| September 30, 2020 | -0.0271M |
| June 30, 2020 | -0.0154M |
| March 31, 2020 | -0.0255M |
| December 31, 2019 | -0.0161M |
| Date | Value |
|---|---|
| September 30, 2019 | -0.0147M |
| June 30, 2019 | -0.0199M |
| March 31, 2019 | -0.0181M |
| December 31, 2018 | -0.0327M |
| September 30, 2018 | -0.0327M |
| June 30, 2018 | -0.0278M |
| March 31, 2018 | -0.0216M |
| December 31, 2017 | -0.0099M |
| September 30, 2017 | -0.016M |
| June 30, 2017 | -0.0886M |
| March 31, 2017 | -0.0968M |
| December 31, 2016 | -0.1046M |
| September 30, 2016 | -0.1026M |
| June 30, 2016 | -0.0308M |
| March 31, 2016 | -0.0206M |
| December 31, 2015 | -0.0202M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-53.71M
Minimum
Jun 2022
-0.0147M
Maximum
Sep 2019
-11.46M
Average
-0.308M
Median
Dec 2021
Cash from Investing (TTM) Benchmarks
| Amgen Inc | -26.20B |
| Johnson & Johnson | 878.00M |
| ResMed Inc | -264.75M |
| Vertex Pharmaceuticals Inc | -3.142B |
| Krystal Biotech Inc | 82.64M |